Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Biomolecules|April 30, 2021
Targeting RIP Kinases in Chronic Inflammatory DiseaseMary Speir, Tirta M Djajawi, Stephanie A Conos, et al.Cell Reports|December 19, 2025
CRISPR screens define unified hallmarks of cancer cell-autonomous immune evasionAnne Huber, Tirta M Djajawi, Isela Sarahi Rivera, et al.Cell Death and Differentiation|September 28, 2022
Mitochondrial E3 ubiquitin ligase MARCHF5 controls BAK apoptotic activity independently of BH3-only proteinsAllan Shuai Huang, Hui San Chin, Boris Reljic, et al.Cell Reports|February 24, 2024
PRMT1 acts as a suppressor of MHC-I and anti-tumor immunityTirta M Djajawi, Lizzy Pijpers, Akash Srivaths, et al.EMBO Reports|October 17, 2023
A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activationMary Speir, Hazel Tye, Timothy A Gottschalk, et al.Blood|June 16, 2022
Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapyRachel Thijssen, Luyi Tian, Mary Ann Anderson, et al.Cell Death and Differentiation|April 9, 2025
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteinsJia-Nan Gong, Tirta M Djajawi, Donia M Moujalled, et al.Cell Death & Disease|February 11, 2023
RIPK3 controls MAIT cell accumulation during development but not during infectionTimothy Patton, Zhe Zhao, Xin Yi Lim, et al.Cell Reports|December 20, 2025
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunityTirta M Djajawi, Anne Huber, Sarahi Mendoza Rivera, et al.Life Science Alliance|November 12, 2024
Divergent roles of RIPK3 and MLKL in high-fat diet-induced obesity and MAFLD in miceHazel Tye, Stephanie A Conos, Tirta M Djajawi, et al.Pageof 2